ASIT Biotech S.A. | |
Stock Exchange | Euronext Brussels |
EPS |
EUR0.86 |
Market Cap |
EUR23.21 M |
Shares Outstanding |
20.48 M |
Public Float |
11.39 M |
Address |
Avenue Ariane 5 Woluwe-Saint-Lambert BU 1200 Belgium |
Employees | - |
Website | http://www.asitbiotech.com |
Updated | 07/08/2019 |
ASIT BioTech SA operates as clinical stage biopharmaceutical company. It focuses on the development and future commercialization of immunotherapy products for the treatment of allergies, based on its ASIT technology platform. The company was founded by Thierry Legon in May 1997 and is headquartered in Brussels, Belgium. |